Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Seminars in Oncology
|
December 10, 1999
The future beyond platinum for the treatment of advanced non-small cell lung cancer
K H Dragnev, J R Rigas
The Oncologist
|
October 21, 2000
The retinoids and cancer prevention mechanisms
K H Dragnev, J R Rigas, E Dmitrovsky
Biochemical Pharmacology
|
December 22, 1995
The chemopreventive agent diallyl sulfide. A structurally atypical phenobarbital-type inducer
K H Dragnev, R W Nims, R A Lubet
Southern Medical Journal
|
April 1, 1998
Thymoma associated with syndrome of inappropriate antidiuretic hormone secretion and myasthenia gravis
A C Donadio, K H Dragnev, G K Schwartz
Annals of the New York Academy of Sciences
|
January 25, 2002
Cyclin proteolysis as a retinoid cancer prevention mechanism
K H Dragnev, S J Freemantle, M J Spinella, et al.
Toxicology and Applied Pharmacology
|
June 1, 1995
Relative potencies of induction of hepatic drug-metabolizing enzyme genes by individual PCB congeners
K H Dragnev, R W Nims, S D Fox, et al.
Journal of Neuro-Oncology
|
June 1, 2005
Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy
C E Fadul, E W Stommel, K H Dragnev, et al.
Journal of Biomedical Optics
|
February 15, 2001
Autofluorescence characteristics of immortalized and carcinogen-transformed human bronchial epithelial cells
J D Pitts, R D Sloboda, K H Dragnev, et al.
Chemico-Biological Interactions
|
August 18, 1995
Effect of dietary Aroclor 1254 exposure on lung and kidney cytochromes P450 in female rats: evidence for P4501A2 expression in kidney
L E Beebe, L W Fornwald, W L Alworth, et al.
Oncogene
|
June 23, 2001
Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function
J C Curtin, K H Dragnev, D Sekula, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Seminars in Oncology
|
December 10, 1999
The future beyond platinum for the treatment of advanced non-small cell lung cancer
K H Dragnev, J R Rigas
The Oncologist
|
October 21, 2000
The retinoids and cancer prevention mechanisms
K H Dragnev, J R Rigas, E Dmitrovsky
Biochemical Pharmacology
|
December 22, 1995
The chemopreventive agent diallyl sulfide. A structurally atypical phenobarbital-type inducer
K H Dragnev, R W Nims, R A Lubet
Southern Medical Journal
|
April 1, 1998
Thymoma associated with syndrome of inappropriate antidiuretic hormone secretion and myasthenia gravis
A C Donadio, K H Dragnev, G K Schwartz
Annals of the New York Academy of Sciences
|
January 25, 2002
Cyclin proteolysis as a retinoid cancer prevention mechanism
K H Dragnev, S J Freemantle, M J Spinella, et al.
Toxicology and Applied Pharmacology
|
June 1, 1995
Relative potencies of induction of hepatic drug-metabolizing enzyme genes by individual PCB congeners
K H Dragnev, R W Nims, S D Fox, et al.
Journal of Neuro-Oncology
|
June 1, 2005
Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy
C E Fadul, E W Stommel, K H Dragnev, et al.
Journal of Biomedical Optics
|
February 15, 2001
Autofluorescence characteristics of immortalized and carcinogen-transformed human bronchial epithelial cells
J D Pitts, R D Sloboda, K H Dragnev, et al.
Chemico-Biological Interactions
|
August 18, 1995
Effect of dietary Aroclor 1254 exposure on lung and kidney cytochromes P450 in female rats: evidence for P4501A2 expression in kidney
L E Beebe, L W Fornwald, W L Alworth, et al.
Oncogene
|
June 23, 2001
Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function
J C Curtin, K H Dragnev, D Sekula, et al.
Page
of 2